MIMO Biosciences: One year driving preclinical research against multiple myeloma

MIMO Biosciences equipo

MIMO Biosciences, member of Navarra Health Cluster, celebrated its first year of activity in February — a journey already marked by key milestones, including its first capital increase at the end of 2024. Ricardo Pérez, CEO of MIMO Biosciences, introduces the company’s work focused on preclinical-stage drug research for various types of haematological cancers, such […]